Literature DB >> 17877919

The role of hypertriglyceridemia in atherosclerosis.

Ngoc-Anh Le1, Mary F Walter.   

Abstract

Atherosclerosis is a chronic disease associated with accumulation of lipids in lesions along blood vessels, leading to the occlusion of blood flow. Much of the focus has been on the role of low-density lipoprotein (LDL), and of oxidatively modified LDL, in the initiation and progression of this disease. LDL is in fact a metabolic end-product of the triglyceride-rich lipoproteins (ie, very-low density lipoproteins). Over the years, univariate analyses have implicated triglycerides as a contributor in atherosclerosis. However, depending on the studies, the significance of this relationship is either reduced or nullified when other co-variates are taken into account. This review summarizes more recent data that support the role of triglyceride-rich lipoproteins in the atherosclerotic process, both in the fasted as well as in the postprandial state.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17877919     DOI: 10.1007/s11883-007-0006-7

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  51 in total

Review 1.  Role of oxidized low density lipoprotein in atherogenesis.

Authors:  J L Witztum; D Steinberg
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

2.  Activated platelets in patients with severe hypertriglyceridemia: effects of triglyceride-lowering therapy.

Authors:  F H de Man; R Nieuwland; A van der Laarse; F Romijn; A H Smelt; J A Gevers Leuven; A Sturk
Journal:  Atherosclerosis       Date:  2000-10       Impact factor: 5.162

3.  Very low density lipoprotein subfractions in Type II diabetes mellitus: alterations in composition and susceptibility to oxidation.

Authors:  J McEneny; M J O'Kane; K W Moles; C McMaster; D McMaster; C Mercer; E R Trimble; I S Young
Journal:  Diabetologia       Date:  2000-04       Impact factor: 10.122

4.  Different effects of diets rich in olive oil, rapeseed oil and sunflower-seed oil on postprandial lipid and lipoprotein concentrations and on lipoprotein oxidation susceptibility.

Authors:  Nina S Nielsen; Anette Pedersen; Brittmarie Sandström; Peter Marckmann; Carl-Erik Høy
Journal:  Br J Nutr       Date:  2002-05       Impact factor: 3.718

Review 5.  Is apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins?

Authors:  Heidelinde Jakel; Maxime Nowak; Audrey Helleboid-Chapman; Jamila Fruchart-Najib; Jean-Charles Fruchart
Journal:  Ann Med       Date:  2006       Impact factor: 4.709

Review 6.  The oxidative modification hypothesis of atherosclerosis: the comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma.

Authors:  Katsuyuki Nakajima; Takamitsu Nakano; Akira Tanaka
Journal:  Clin Chim Acta       Date:  2006-01-30       Impact factor: 3.786

7.  Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.

Authors:  J E Hokanson; M A Austin
Journal:  J Cardiovasc Risk       Date:  1996-04

8.  Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation: prevention by cilostazol.

Authors:  Hwa Kyoung Shin; Yong Ki Kim; Ki Young Kim; Jeong Hyun Lee; Ki Whan Hong
Journal:  Circulation       Date:  2004-02-16       Impact factor: 29.690

9.  Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment.

Authors:  Antoniom Ceriello; Lisa Quagliaro; Ludovica Piconi; Roberta Assaloni; Roberto Da Ros; Amabile Maier; Katherine Esposito; Dario Giugliano
Journal:  Diabetes       Date:  2004-03       Impact factor: 9.461

Review 10.  Lipoprotein oxidation in cardiovascular disease: chief culprit or innocent bystander?

Authors:  Jay W Heinecke
Journal:  J Exp Med       Date:  2006-04-10       Impact factor: 14.307

View more
  20 in total

1.  Effects of oral and intravenous fat load on blood pressure, endothelial function, sympathetic activity, and oxidative stress in obese healthy subjects.

Authors:  Aidar R Gosmanov; Dawn D Smiley; Gonzalo Robalino; Joselita Siquiera; Bobby Khan; Ngoc-Anh Le; Riyaz S Patel; Arshed A Quyyumi; Limin Peng; Abbas E Kitabchi; Guillermo E Umpierrez
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-10-05       Impact factor: 4.310

2.  Plasma prekallikrein levels are positively associated with circulating lipid levels and the metabolic syndrome in children.

Authors:  James A MacKenzie; Kristen A Roosa; Brooks B Gump; Amy K Dumas; Kestutis G Bendinskas
Journal:  Appl Physiol Nutr Metab       Date:  2010-08       Impact factor: 2.665

Review 3.  Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2013-10-21

4.  Postprandial lipemia detects the effect of soy protein on cardiovascular disease risk compared with the fasting lipid profile.

Authors:  Antonio S Santo; Ariana M Santo; Richard W Browne; Harold Burton; John J Leddy; Steven M Horvath; Peter J Horvath
Journal:  Lipids       Date:  2010-10-28       Impact factor: 1.880

5.  A liver-enriched long non-coding RNA, lncLSTR, regulates systemic lipid metabolism in mice.

Authors:  Ping Li; Xiangbo Ruan; Ling Yang; Kurtis Kiesewetter; Yi Zhao; Haitao Luo; Yong Chen; Marjan Gucek; Jun Zhu; Haiming Cao
Journal:  Cell Metab       Date:  2015-03-03       Impact factor: 27.287

Review 6.  Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs.

Authors:  Richard Kones; Umme Rumana
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546

7.  Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial, and fenofibrate-treated states.

Authors:  Pablo Perez-Martinez; Dolores Corella; Jian Shen; Donna K Arnett; Nikos Yiannakouris; E Syong Tai; Marju Orho-Melander; Katherine L Tucker; Michael Tsai; Robert J Straka; Michael Province; Chew Suok Kai; Francisco Perez-Jimenez; Chao-Qiang Lai; Jose Lopez-Miranda; Marisa Guillen; Laurence D Parnell; Ingrid Borecki; Sekar Kathiresan; Jose M Ordovas
Journal:  Am J Clin Nutr       Date:  2008-12-03       Impact factor: 7.045

Review 8.  Lipid peroxidation and decomposition--conflicting roles in plaque vulnerability and stability.

Authors:  Sampath Parthasarathy; Dmitry Litvinov; Krithika Selvarajan; Mahdi Garelnabi
Journal:  Biochim Biophys Acta       Date:  2008-03-25

9.  The structure of helical lipoprotein lipase reveals an unexpected twist in lipase storage.

Authors:  Kathryn H Gunn; Benjamin S Roberts; Fengbin Wang; Joshua D Strauss; Mario J Borgnia; Edward H Egelman; Saskia B Neher
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-24       Impact factor: 11.205

10.  Simvastatin does not affect vitamin d status, but low vitamin d levels are associated with dyslipidemia: results from a randomised, controlled trial.

Authors:  Lars Rejnmark; Peter Vestergaard; Lene Heickendorff; Leif Mosekilde
Journal:  Int J Endocrinol       Date:  2009-07-21       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.